Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization

Cancer Genetics and Cytogenetics

Volumn 101, Issue 1, 1998, Pages 53-57

  Nupponen, Nina N ^a   Hyytinen, Eija R ^a   Kallioniemi, Anne H ^b   Visakorpi, Tapio ^a  

^a UNIVERSITY OF TAMPERE   (Finland)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME ABERRATION; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; HYBRIDIZATION; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE CANCER;

DNA, NEOPLASM; GENE AMPLIFICATION; HUMANS; MALE; NUCLEIC ACID HYBRIDIZATION; PROSTATIC NEOPLASMS;

EID: 0032006294     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00060-5     Document Type: Article

References (22)

1. Vogelstein B, Kinzler KW (1993): The multistep nature of cancer. Trends Genet 9:138-141.
2. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP (1983): LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1818.
3. Izumi T, Yazaki T, Kanoh S, Kondo I, Koiso K (1987): Establishment of a new prostatic carcinoma cell line (TSU-PR1). J Urol 137:1304-1306.
4. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF (1978): Isolation of a human prostate carcinoma cell line (DU-145). Int J Cancer 21:274-281.
5. Kaighn ME, Narayan S, Ohnuki Y, Lechner JF, Jones LW (1979): Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17:16-23.
6. Gibas Z, Becher R, Kawinski E, Horoszewicz J, Sandberg AA (1984): A high-resolution study of chromosome changes in a human prostatic carcinoma cell line. Cancer Genet Cytogenet 11:399-404.
7. Wu HS, Hsieh JT, Gleave ME, Brown NM, Pathak S, Chung L (1994): Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int J Cancer 57:406-412.
8. Brothman AR, Peehl DM, Patel AM, McNeal JE (1990): Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50:3795-3803.
9. Ohnuki Y, Marnell MM, Babcock MS, Lechner JF, Kaighn ME (1980): Chromosomal analysis of human prostatic adenocarcinoma cell lines. Cancer Res 40:524-534.
10. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992): Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
11. duManoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T (1993): Detection of complete and partial chromosomal gains and losses by comparative genomic hybridization. Hum Genet 90:590-610.
12. Piper J, Rutowitz D, Sudar D, Kallioniemi A, Kallioniemi OP, Waldman FM, Gray JW, Pinkel D (1994): Computer image analysis of comparative genomic hybridization. Cytometry 19:10-26.
13. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D (1994): Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 10:231-243.
14. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim J, Chai LS, Kakati S, Araya SK, Sandberg AA (1980): The LNCaP cell line - a new model for studies on human prostatic carcinoma. In: Models for Prostate Cancer. GP Murphy, ed. Alan R. Liss Inc., New York, pp. 115-132.
15. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH (1994): Comparative genomic hybridization, allelic imbalance and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosom Cancer 11:153-162.
16. Visakorpi T, Kallioniemi A, Syvänen AC, Hyytinen E, Karhu R, Tammela T, Isola J, Kallioniemi OP (1995): Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
17. Joos S, Bergerheim U, Pan Y, Matsuyama H, Bentz M, du Manoir S, Lichter P (1995): Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosom Cancer 14:267-276.
18. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH (1996): Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102.
19. Hyytinen ER, Thalmann GN, Zhau HE, Karhu R, Kallioniemi O-P, Chung LWK, Visakorpi T (1997): Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity, and metastatic potential in a prostate cancer model. Br J Cancer 75:190-195.
20. Sandberg AA (1992): Chromosomal abnormalities and related events in prostate cancer. Hum Pathol 23:368-380.
21. Van Den Berg C, Guan X-Y, Von Hoff D, Jenkins R, Bittner M, Griffin C, Kallioniemi O-P, Visakorpi T, McGill J, Herath J, Epstein J, Sarosdy M, Meltzer P, Trent J (1995): DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. Clin Cancer Res 1:11-18.
22. 0) prostate carcinoma. Clin Cancer Res 2:137-145.